40 Canagliflozin, a New Anti-Diabetic Agent Targeting Cellular Metabolism, Suppresses Survival and Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiotherapy. (October 2019) - Biziotis, Olga-Demetra; Tsakiridis, Evangelia - Evelyn; Broadfield, Lindsay; Farrell, Thomas; Menjolian, Gabe; Mathurin, Tammy; Mekhaeil, Bassem; Zacharidis, Panagiotis; Muti, Paola; Abdulkarim, Bassam; Steinberg, Gregory; Tsakiridis, Theodoros